Wellington Management Group
ORKA

Wellington Management Group’s Oruka Therapeutics ORKA Stock Holding History

Wellington Management Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.95M Buy
121,225
+36,509
+43% +$1.27M ﹤0.01% 1374
2025
Q4 		$2.57M Sell
84,716
-6,378
-7% -$178K ﹤0.01% 1535
2025
Q3 		$1.75M Buy
+91,094
New +$1.35M ﹤0.01% 1665
2025
Q2 		– Sell
-87,501
Closed -$898K – 2075
2025
Q1 		$898K Sell
87,501
-7,588
-8% -$94.6K ﹤0.01% 1726
2024
Q4 		$1.84M Buy
95,089
+12,952
+16% +$316K ﹤0.01% 1585
2024
Q3 		$2.01M Buy
+82,137
New +$2.86M ﹤0.01% 1538

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Wellington Management Group's ORKA Position: Q1 2026 in Review

Wellington Management Group increased its Oruka Therapeutics (ORKA) stake by 43% in Q1 2026, buying an estimated $1.27M and bringing the position to 121,225 shares worth $5.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Wellington Management Group first reported a position in ORKA in Q3 2024 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Wellington Management Group held 121,225 shares of Oruka Therapeutics worth $5.95M as of Q1 2026.
  • Wellington Management Group bought 36,509 Oruka Therapeutics shares in Q1 2026, an estimated $1.27M.
  • Oruka Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1374 holding.
  • Wellington Management Group first reported a position in Oruka Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.